Citichem India IPO Review

Citichem India IPO Review – Apply or not

Citichem India IPO presents an intriguing opportunity for investors, with a book-built issue valued at ₹12.60 crores. The offering consists of a fresh issue of 18.00 lakh shares, raising ₹12.60 crores, aimed at funding the company’s growth and operational requirements. This IPO provides a mix of growth capital and liquidity for stakeholders, making it a noteworthy event for market participants keen on exploring new investment opportunities.

The IPO is open for subscription from December 27, 2024 and closes on December 31, 2024, offering investors a limited window to participate in this opportunity. The price band is set between ₹70 per share, providing flexibility for bidders within this range. Investors can apply in multiples of the lot size of 2,000 shares, making the minimum investment of 1,40,000. With its structured bidding process and competitive pricing, this IPO is set to attract attention from retail and institutional investors alike. Citichem India IPO will list on NSE SME with tentative listing date fixed as Thursday, January 3, 2025.

Refer to Citichem India IPO RHP for detailed information.

Citichem India IPO Details

IPO DateDecember 27, 2024 to December 31, 2024
Listing Date 03 January, 2025
Face value₹10 per share
Price band₹70 per share
Lot size2,000 Shares
Total Issue Size18,00,000 shares (aggregating up to ₹44.80 Cr)
Fresh Issue18,00,000 shares (aggregating up to ₹ 44.80 Cr)
Offer for Sale0
Issue TypeFixed Price Issue IPO
Listing At
NSE SME
Share Holding Post Issue68,00,000 shares
Market Maker Portion92,000 shares Aftertrade Broking Pvt Ltd

Citichem India IPO Lot Size calculator

ApplicationLotsShareAmount
Retail (Min)110,000₹1,40,000
Retail (Max)110,000₹1,40,000
HNI (Min)220,000₹2,80,000

Citichem India IPO Distribution

Investor CategoryShares Offered
Anchor Investor Shares Offered
Market Maker Shares Offered92,000 (5.11%)
Other Share Offered8,54,000 (47.44%)
Retail Shares Offered8,54,000 (47.44%)
NII (HNI) Shares Offered18,00,001 (100%)

Citichem India Company

Established in 1992, Citichem India Limited specializes in procuring and supplying organic and inorganic chemicals, bulk drugs, and food chemicals to the pharmaceutical industry.

The company prioritizes the direct supply of specialty chemicals, bulk drugs, and intermediates, catering to diverse sectors.

Its product range includes specialty chemicals and intermediates with applications across industries such as aluminum, steel, textiles, paper, dairy, paints, dyes, soap manufacturing, pharmaceuticals, food, and adhesives.

Additionally, the company markets food preservatives and chemicals under its brand, distributed through a dedicated network to ensure safe bulk deliveries.

Key products include Caustic Soda Flakes, Caustic Soda Lye, Citric Acid Monohydrate, Hydrogen Peroxide, and more.

Business Divisions

  1. Specialty Chemicals, Intermediates & Active Pharmaceutical Ingredients (API): Expertise in indenting, sourcing, make-to-order outsourcing, and supplying specialty chemicals, bulk drugs, and APIs for pharmaceutical, paint, and food industries, serving domestic and global clients.
  2. Food Chemicals: Engages in repackaging, retail distribution, and marketing of food-grade chemicals.
  3. Laboratory Chemicals: Offers a comprehensive range of laboratory chemical solutions.

As of June 30, 2024, the company has a team of 9 employees.

Competitive Strengths

  • Experienced promoters and management team
  • Scalable business model
  • Commitment to quality and innovation
  • Strategic location advantage
  • Strong relationships with suppliers and customers
  • Dedicated after-sales network

Citichem India Company Finances

Amount in ₹ Lakhs

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Total Borrowing108.21108.21109.65110.62
Assets6,851.566,932.797,972.539,142.69
Revenue149.071,960.582,094.078,528
Profit after tax19.95111.8336.2623.94
Net Worth745.06725.11613.27577.01
Reserves and Surplus245.06225.11113.2777.01

Citichem India IPO – Apply or Not

Citichem India IPO appears to be a promising opportunity, especially given the current market sentiment and the company’s strong fundamentals. The IPO is an SME offering, which inherently carries potential for significant listing gains, often in the range of 2X to 3X. Despite not being open yet, the Grey Market Premium (GMP) is already at 42.86%, reflecting strong investor interest and positive anticipation. The company, established in 1992, has built a solid foundation in the fertilizers and packaging sectors, showcasing consistent growth with a turnover exceeding ₹20 crores. Its diverse product portfolio, focus on customer needs, and emphasis on quality and technological upgrades enhance its competitive edge in the market. For investors looking for both short-term and long-term opportunities, this IPO is worth considering. Applying in this IPO could be a strategic move to capitalize on potential listing gains, and for those with a higher risk appetite, holding the stock with a proper trailing stop loss could yield further benefits, as the company’s fundamentals support sustainable growth over time.

Citichem India IPO Prospectus

Read our other articles(IPO Insights)

Leave a Reply

Your email address will not be published. Required fields are marked *